Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentöse Tumortherapie

Currently, there is no standard systemic treatment for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue. Both rituximab and cladribine have shown some activity in this disease, but the combination has not been tested so far. In view of this, we initiated a phase II s...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Marlene Troch, Barbara Kiesewetter, Wolfgang Willenbacher, Ella Willenbacher, Armin Zebisch, Werner Linkesch, Michael Fridrik, Leonhard Müllauer, Richard Greil, Markus Raderer
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Ferrata Storti Foundation 2013-02-01
Edice:	Haematologica
On-line přístup:	https://haematologica.org/article/view/6563
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!